文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

面罩无创正压通气与经鼻高流量湿化氧疗对病毒性肺炎所致ARDS患者气管插管率的影响

[Effect of noninvasive positive pressure ventilation by face mask versus nasal high-flow humidified oxygen therapy on the rate of endotracheal intubation in patients with acute respiratory distress syndrome due to viral pneumonia].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论病毒性肺炎所致ARDS患者中,面罩无创正压通气较经鼻高流量湿化氧疗显著降低气管插管率(25.0% vs 38.6%),尤其65岁以上患者,但不降低死亡率。

该回顾性研究纳入2023年1月1日至2024年12月31日新疆医科大学第一附属医院呼吸重症监护病房(RICU)收治的病毒性肺炎所致ARDS患者205例,按初始呼吸支持方式分为面罩无创正压通气(NPPV)组104例和经鼻高流量湿化氧疗(HFNC)组101例,并按中重度ARDS患者数量进行匹配。主要终点为气管插管。结果显示NPPV组气管插管率显著低于HFNC组(25.0% vs 38.6%,P<0.05),65岁以上患者中同样显著降低(27.8% vs 45.2%,P<0.05);NPPV组心率、呼吸频率下降及氧合指数升高更明显,RICU住院时间更短,但并发症发生率更高(30.8% vs 5.9%,P<0.05),死亡率无显著差异(13.5% vs 16.8%,P>0.05)。

要点

  • 病毒性肺炎所致ARDS患者中,面罩NPPV组气管插管率25.0%(26/104)显著低于HFNC组38.6%(39/101)(P<0.05)。
  • 65岁以上患者中,NPPV组气管插管率27.8%(20/72)显著低于HFNC组45.2%(33/73)(P<0.05)。
  • NPPV组并发症(误吸、腹胀、鼻面部皮肤损伤、不耐受)发生率30.8%(32/104)显著高于HFNC组5.9%(6/101)(P<0.05)。
  • NPPV组RICU住院时间10.0(7.0,14.5)天显著短于HFNC组14.0(9.0,20.0)天(P<0.05),但死亡率13.5%(14/104)与16.8%(17/101)无显著差异(P>0.05)。
  • 治疗24小时和72小时,NPPV组心率、呼吸频率下降及氧合指数升高均较HFNC组更明显(均P<0.05)。

适用人群与场景

  • 2023年1月1日至2024年12月31日新疆医科大学第一附属医院RICU收治的病毒性肺炎所致ARDS患者205例,按初始呼吸支持方式分为NPPV组104例和HFNC组101例,并按中重度ARDS患者数量匹配。

研究设计与关键结果

  • 回顾性研究,纳入205例病毒性肺炎所致ARDS患者,NPPV组104例、HFNC组101例,两组性别、年龄、生命体征、疾病严重程度、基础疾病及感染病毒类型均无统计学显著差异(均P>0.05)。
  • 主要终点气管插管率:NPPV组25.0%(26/104) vs HFNC组38.6%(39/101),P<0.05;65岁以上患者中NPPV组27.8%(20/72) vs HFNC组45.2%(33/73),P<0.05。
  • 24小时心率变化:NPPV组-29.00(-42.00,-16.00)次/min vs HFNC组-23.00(-37.00,-6.00)次/min;72小时心率变化:NPPV组-36.83±19.06次/min vs HFNC组-28.29±19.53次/min。
  • 24小时呼吸频率变化:NPPV组-7.6±5.8次/min vs HFNC组-5.0±4.8次/min;72小时呼吸频率变化:NPPV组-9.5(-13.0,-5.0)次/min vs HFNC组-8.0(-10.0,-4.0)次/min。
  • 24小时氧合指数变化:NPPV组43.0(5.0,76.0)mmHg vs HFNC组23.0(-2.0,46.0)mmHg;72小时氧合指数变化:NPPV组60.6±77.7 mmHg vs HFNC组38.7±67.6 mmHg(1 mmHg=0.133 kPa),均P<0.05。
  • 并发症(误吸、腹胀、鼻面部皮肤损伤、不耐受)发生率:NPPV组30.8%(32/104) vs HFNC组5.9%(6/101),P<0.05。
  • RICU住院时间:NPPV组10.0(7.0,14.5)天 vs HFNC组14.0(9.0,20.0)天,P<0.05;死亡率:NPPV组13.5%(14/104) vs HFNC组16.8%(17/101),P>0.05。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于病毒性肺炎所致ARDS患者,与HFNC相比,面罩NPPV可降低气管插管率,尤其在65岁以上患者中,但并发症(误吸、腹胀、鼻面部皮肤损伤、不耐受)发生率更高,死亡率无显著差异;作者结论认为NPPV显著降低气管插管率但不降低死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare the impact of noninvasive positive pressure ventilation (NPPV) by face mask versus high-flow nasal cannula (HFNC) oxygen therapy on the endotracheal intubation rate in patients with acute respiratory distress syndrome (ARDS) caused by viral pneumonia.

METHODS: A retrospective study was conducted. ARDS patients with viral pneumonia were treated in the respiratory intensive care unit (RICU) of the First Affiliated Hospital of Xinjiang Medical University from January 1, 2023 to December 31, 2024, and they were divided into NPPV group and HFNC group according to initial respiratory support methods, with matching for the number of patients with moderate-to-severe ARDS. The primary endpoint was endotracheal intubation. Baseline data including demographic characteristics, vital signs, disease severity, underlying diseases, and types of infecting viruses at admission were compared between the two groups. Changes in respiratory support indicators at 24 hours and 72 hours of treatment, related complications, endotracheal intubation rate, the length of RICU stay and mortality were also compared.

RESULTS: A total of 205 patients were enrolled, with 104 in the NPPV group and 101 in the HFNC group. There were no statistically significant differences in gender, age, vital signs, disease severity, underlying diseases, and types of infecting viruses between the two groups (all P > 0.05), indicating that the two groups were comparable. Compared to the HFNC group, the NPPV group showed more significant reductions in heart rate (HR) and respiratory rate (RR) at both 24 hours and 72 hours of treatment [change in HR (ΔHR, bpm) at 24 hours, 72 hours: -29.00 (-42.00, -16.00) vs. -23.00 (-37.00, -6.00), -36.83±19.06 vs. -28.29±19.53; change in RR (ΔRR, bpm): -7.6±5.8 vs. -5.0±4.8, -9.5 (-13.0, -5.0) vs. -8.0 (-10.0, -4.0)], and a more marked increase in the oxygenation index (PaO2/FiO2) [change in PaO2/FiO2 (ΔPaO2/FiO2, mmHg, 1 mmHg = 0.133 kPa ): 43.0 (5.0, 76.0) vs. 23.0 (-2.0, 46.0), 60.6±77.7 vs. 38.7±67.6], all differences were statistically significant (all P < 0.05). Compared with the HFNC group, the NPPV group showed a significant decrease in endotracheal intubation rate [25.0% (26/104) vs. 38.6% (39/101), P < 0.05], so did in patients over 65 years old [27.8% (20/72) vs. 45.2% (33/73), P < 0.05]. The incidence of complications such as aspiration, abdominal distension, nasal and facial skin lesions, and intolerance in the NPPV group was significantly higher than that in the HFNC group [30.8% (32/104) vs. 5.9% (6/101), P < 0.05], and the length of RICU stay was significantly shortened [days: 10.0 (7.0, 14.5) vs. 14.0 (9.0, 20.0), P < 0.05], however, there was no significant difference in mortality [13.5% (14/104) vs. 16.8% (17/101), P > 0.05].

CONCLUSIONS: For patients with ARDS due to viral pneumonia, NPPV significantly reduces the endotracheal intubation rate when compared with HFNC, particularly in elderly patients, but does not reduce mortality.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Shen J, Wei C, Wu X, et al. [Effect of noninvasive positive pressure ventilation by face mask versus nasal high-flow humidified oxygen therapy on the rate of endotracheal intubation in patients with acute respiratory distress syndrome due to viral pneumonia]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41437586. doi:10.3760/cma.j.cn121430-20250611-00564

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。